ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,17
-0,13%
Dow Jones
42.313,00
0,33%
Euro vs US Dollar
1,11669
-0,08%
Bitcoin
65.849,76
1,02%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) News

HROW

Harrow (HROW)

Harrow Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HROW
DatumZeitQuelleÜberschriftSymbolFirma
25/09/202418h02Business WireHarrow Announces Nashville ExpansionNASDAQ:HROWHarrow Inc
03/09/202413h00Business WireHarrow to Present at Three Investor Conferences in September in New YorkNASDAQ:HROWHarrow Inc
07/08/202423h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HROWHarrow Inc
07/08/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
07/08/202422h01Business WireHarrow Announces Second Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
25/07/202413h00Business WireHarrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024NASDAQ:HROWHarrow Inc
12/07/202413h00Business WireHarrow to Attend 2024 ASRS Annual MeetingNASDAQ:HROWHarrow Inc
09/07/202413h00Business WireHarrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow ProductsNASDAQ:HROWHarrow Inc
20/06/202413h00Business WireHarrow Provides TRIESENCE® Relaunch UpdateNASDAQ:HROWHarrow Inc
06/06/202414h00Business WireMelt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract SurgeryNASDAQ:HROWHarrow Inc
05/06/202413h00Business WireHarrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension StudyNASDAQ:HROWHarrow Inc
15/05/202413h00Business WireHarrow to Present at Two Investor Conferences in MayNASDAQ:HROWHarrow Inc
13/05/202422h01Business WireHarrow Announces First Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
13/05/202413h00Business WireHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialNASDAQ:HROWHarrow Inc
25/04/202413h00Business WireHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASDAQ:HROWHarrow Inc
02/04/202414h16Business WireMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingNASDAQ:HROWHarrow Inc
20/03/202412h15IH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:HROWHarrow Inc
19/03/202422h45Business WireHarrow Announces Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:HROWHarrow Inc
19/03/202412h27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:HROWHarrow Inc
06/03/202412h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
05/03/202413h00Business WireHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024NASDAQ:HROWHarrow Inc
22/02/202401h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
22/02/202401h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
15/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
15/02/202422h01Business WireHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical ProductsNASDAQ:HROWHarrow Inc
09/02/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HROWHarrow Inc
08/02/202413h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
29/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
29/01/202421h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
29/01/202413h00Business WireHarrow Announces New Appointments to its Board of DirectorsNASDAQ:HROWHarrow Inc
 Showing the most relevant articles for your search:NASDAQ:HROW

Kürzlich von Ihnen besucht

EU
IPRP
iShares European Propert...
NASDAQ
DFCT
D F China
LSE
35CV
Euro.bk. 39
TG
A185Y4
Saipem Finance
LATK
BALUSDT
Balancer
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten